Search

everythinglearnresearchcommunity

for

Search:↓

The conclusion is that we need more effective hair loss treatments than the current ones, and these could include new drugs, gene and stem cell therapy, hormones, and scalp cooling, but they all need thorough safety testing.

Stress may affect hair growth by influencing hair follicle development and could contribute to hair loss.

COVID-19 can cause skin issues like "COVID toes," rashes, hair loss, and hand eczema, and dermatologists are important for recognizing these signs.

Lupus is a complex disease that requires personalized treatment because it varies greatly between individuals.

TYK2 inhibitors show promise for treating cancer and autoimmune disorders.

A group has developed therapies that show promise for treating cancer and various other conditions.

New treatments targeting the JAK signaling pathway, especially JAK inhibitors, show promise for alopecia areata.

Activating PKCα in skin causes cell death and inflammation through different pathways.

Alopecia areata causes sudden, patchy hair loss due to immune system attacks on hair follicles.

Alopecia areata causes sudden, patchy hair loss due to immune system attacks on hair follicles.

Intralesional triamcinolone acetonide can regrow hair in alopecia areata but often has temporary effects and side effects.

Type 1 diabetes may cause certain autoimmune diseases in Europeans.

Four antibodies were developed to help study hair follicle cell differentiation.

This method is effective for needle-free HIV-1 vaccination by activating immune responses in the skin.

Alopecia areata is a skin condition causing hair loss, and its exact cause is unknown, but it may involve biological mechanisms.

TGF-alpha is present in sheep and ferret skin and may affect hair growth without directly stimulating cell proliferation.

The arrector pili muscle plays a key role in hair loss in androgenetic alopecia.

Upadacitinib effectively improved severe atopic dermatitis and alopecia universalis in a 29-year-old man.

Corticosteroid therapy reduces specific immune cells and promotes hair growth in alopecia areata patients.

Many patients with Alopecia Areata have underlying autoimmune disorders, especially thyroid issues.

An 87-year-old woman was diagnosed with type 3 autoimmune polyendocrine syndrome and had multiple autoimmune issues.

Anti-Desmocollin 3 antibodies can cause atypical pemphigus symptoms.

Androgenetic alopecia may be irreversible due to the detachment of a muscle from hair follicles.

Cicatricial alopecia may be caused by immune attacks on hair follicles, gland issues, or stem cell damage.

A potential treatment for atopic dermatitis could be to increase PADI1 expression to improve skin barrier function.

Alopecia areata treatments include immune inhibitors, topical sensitizers, irritants, and minoxidil, with future focus on immunosuppressive approaches.

ACKR2 helps prevent skin scarring and hair loss by controlling inflammation.

Alopecia Areata affects 2% globally, with treatments like essential oils, garlic, and JAK inhibitors showing promise, but more research is needed.

The AA-IGA scale reliably measures treatment success in alopecia areata by considering both clinician and patient views.

Dupilumab for skin problems might reactivate hair loss in some patients.